Esteban Jódar-Gimeno

10PUBLICATIONS
26CO-AUTHORS
Clinical chemistry (incl. diagnostics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 14, 2025
Analysis of the Efficacy and Safety of Weekly Calcifediol 100 µg in Vitamin D Deficient Patients.

Jose Luis Pérez Castrillón, Esteban Jódar-Gimeno, Koldobika Molina

|May 05, 2025
Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.

Ildiko Lingvay, Malik Benamar, Liming Chen

|Feb 26, 2025
A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency.

Jose Luis Pérez-Castrillón, Esteban Jódar-Gimeno, Ján Nociar

|Jan 17, 2025
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.

Ildiko Lingvay, Malik Benamar, Liming Chen

|Dec 30, 2024
Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) Study.

Francisco Jesús Olmo-Montes, José Ramón Caeiro-Rey, Pilar Peris

|Nov 27, 2024
Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial.

Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar

Pageof 2

Frequent Collaborators

3 joint publications

Jose Luis Pérez-Castrillón

2 joint publications

Ariel Fu

2 joint publications

Daisuke Yabe

2 joint publications

Tomoyuki Nishida